FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:1267-1271 May 5, 1994 Number 18 Next

Abstract Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Helicobacter pylori infection is a risk factor for gastric adenocarcinoma. We examined whether this infection is also a risk factor for primary gastric non-Hodgkin's lymphoma.

Methods This nested case-control study involved two large cohorts (230,593 participants). Serum had been collected from cohort members and stored, and all subjects were followed for cancer. Thirty-three patients with gastric non-Hodgkin's lymphoma were identified, and each was matched to four controls according to cohort, age, sex, and date of serum collection. For comparison, 31 patients with nongastric non-Hodgkin's lymphoma from one of the cohorts were evaluated, each of whom had been previously matched to 2 controls. Pathological reports and specimens were reviewed to confirm the histologic type of the tumor. Serum samples from all subjects were tested for H. pylori IgG by an enzyme-linked immunosorbent assay.

Results Thirty-three cases of gastric non-Hodgkin's lymphoma occurred a median of 14 years after serum collection. Patients with gastric lymphoma were significantly more likely than matched controls to have evidence of previous H. pylori infection (matched odds ratio, 6.3; 95 percent confidence interval, 2.0 to 19.9). The results were similar in both cohorts. Among the 31 patients with nongastric lymphoma, a median of six years had elapsed between serum collection and the development of disease. No association was found between nongastric non-Hodgkin's lymphoma and previous H. pylori infection (matched odds ratio, 1.2; 95 percent confidence interval, 0.5 to 3.0).

Conclusions Non-Hodgkin's lymphoma affecting the stomach, but not other sites, is associated with previous H. pylori infection. A causative role for the organism is plausible, but remains unproved.

Circumstantial evidence suggests that infection with a bacterium, Helicobacter pylori, may increase the risk of gastric non-Hodgkin's lymphoma. Sixty percent of gastric non-Hodgkin's lymphomas evolve from chronic gastritis, a lesion usually caused by H. pylori⁸. In a study of adenocarcinoma, an unexpected link between H. pylori infection and the subsequent development of gastric non-Hodgkin's lymphoma was identified, although this association was not statistically significant⁹. Furthermore, a region in Europe with a high incidence of gastric non-Hodgkin's lymphoma had a higher rate of H. pylori infection than a region with a low incidence¹⁰. A possible association between H. pylori and non-Hodgkin's lymphoma was also seen in a large multiregion study in China, although the primary sites of the lymphomas were not identified¹¹. Two studies have demonstrated high rates of H. pylori infection in patients with gastric non-Hodgkin's lymphoma^12,13; one linked infection to a specific type of tumor derived from mucosa-associated lymphoid tissue (MALT lymphomas)¹³.

To address the association of H. pylori with primary gastric non-Hodgkin's lymphoma, we conducted a nested case-control study within two very large cohorts using a serologic marker for infection with the bacterium. Because we hypothesized that any association of H. pylori with lymphoma should be specific to gastric sites, we also evaluated the association of H. pylori with nongastric lymphomas.

Methods

Subjects

A case of gastric non-Hodgkin's lymphoma was defined as lymphoma restricted to the stomach and adjacent lymph nodes. Patients with gastric non-Hodgkin's lymphoma were identified in two large cohorts. The Kaiser-Orentreich cohort consisted of 128,992 members of a health maintenance organization (the Kaiser Permanente Medical Group) who had provided serum between 1964 and 1969 as part of a routine multiphasic health evaluation. Since 1980, these serum samples have been catalogued and maintained at -40 °C by the Orentreich Foundation (Cold Spring, N.Y.)¹⁴. Members of the cohort in whom gastric non-Hodgkin's lymphoma subsequently developed were identified by linkage with computerized tumor-registry and hospitalization data. The Janus cohort included 170,000 persons who donated blood and participated in various health screening programs in Norway from 1973 to 1991^15,16; of these, 101,601 were eligible for selection as case patients or controls, since both cancer-registry data and serum samples were available. Members of the cohort in whom gastric non-Hodgkin's lymphoma developed through 1990 were identified by linkage with the Norwegian Cancer Registry.

Nineteen patients with gastric non-Hodgkin's lymphoma were identified in the Kaiser-Orentreich cohort and 13 in the Janus cohort. The medical records of these patients were reviewed, and pathological specimens were reexamined by pathologists at Stanford University to confirm the histologic type of the tumor. Lesions were classified according to the cytomorphologic criteria of the working formulation⁴. Low-grade MALT lymphomas were defined according to the criteria of Isaacson¹⁷. In cases in which there were differences in the histologic interpretation between the original and reviewing pathologists, immunohistochemical studies were performed^18,19.

Patients identified as having gastric non-Hodgkin's lymphoma were matched according to cohort, date of birth (in the Kaiser-Orentreich cohort the controls were obtained from the same five-year birth cohort; in the Janus cohort the controls were matched for the date of birth plus or minus six months), sex, and date and site of serum collection to four randomly chosen control subjects in whom cancer had not developed as of the year gastric non-Hodgkin's lymphoma was diagnosed in the case patient. Case patients from the Kaiser-Orentreich cohort were also matched according to racial or ethnic group. There are no corresponding data on the predominantly white Janus cohort.

To identify a group of patients with nongastric non-Hodgkin's lymphoma for comparative purposes, serum samples were obtained from a previous nested case-control study of this lymphoma in the Kaiser-Orentreich cohort²⁰. In this earlier study, 44 patients with non-Hodgkin's lymphoma had each been matched to 2 controls as described above. Two of these patients had gastric lymphoma and were also identified by our computerized analysis of the Kaiser-Orentreich cohort. All 12 controls for these 2 patients (4 each from the recent linkage analysis and 2 each from the previous analysis) were included in the analysis. On review of the histopathological information, an additional patient with gastric lymphoma was identified who was not identified by computerized analysis of the Kaiser-Orentreich cohort. This patient and two matched controls were also included in the matched analysis of gastric non-Hodgkin's lymphoma.

Of the 41 remaining patients who were identified in the earlier study of non-Hodgkin's lymphoma, 6 had no pathological specimens available for review and in 3 others the diagnosis of lymphoma could not be confirmed. These nine patients were excluded. An additional patient was found to have widely disseminated disease involving the stomach. Because the primary site of cancer could not be confirmed, this patient was also excluded. One patient had only one control because there were no serum samples remaining for the other control. Thus, a total of 31 patients with nongastric non-Hodgkin's lymphoma and 61 matched controls were evaluated. The histologic analyses of lymphoma had previously been confirmed by pathologists at Harvard University, Stanford University, or both. Seventeen were primary tumors of the lymph nodes. The remaining tumors were widely disseminated without gastric involvement (three) or were primary cancers of the mesentery, omentum, or intestine (four); nasopharynx or thyroid (two each); or larynx, parotid gland, or retroperitoneum (one each).

Serologic Assays

All serum samples had been maintained at -20 °C or lower^14,15. The aliquots were coded and sent to Stanford University, where they were tested by workers who were unaware of the case or control status of the specimens. Titers of anti-H. pylori IgG were assayed by a serum enzyme-linked immunosorbent assay (ELISA) as previously described⁹. The antigens included the high-molecular-weight, cell-associated proteins of three H. pylori strains. Dominant bands elicited by sodium dodecyl sulfate-polyacrylamide-gel electrophoresis included proteins at 66, 57, and 29 kd. Other bands occurred at 83, 53, and 26 kd. These antigens, which include the urease subunits and the cytotoxin, are similar to those described for other H. pylori ELISAs²¹. Any subject with a serum titer higher than 3 SD above the mean of 15 negative control standards was considered to have been infected with H. pylori at the time of serum collection. This assay had a sensitivity of 96 percent and a specificity of 76 percent for active gastric infection, on the basis of an analysis of 124 biopsy-confirmed serum samples from the United States, Latin America, and Asia (75 positive and 49 negative). Because biopsy specimens may not include tissue from an active site of a patchy infection, the calculated specificity is most likely an underestimate of the true specificity²². Serologic tests accurately reflect the presence or absence of active H. pylori infection, except in the very elderly, in whom titers may be falsely negative^23,24. A positive titer therefore strongly supports the presence of an ongoing, rather than past, infection.

Statistical Analysis

Data were entered and analyzed with EpiInfo (Centers for Disease Control and Prevention, Atlanta) and Egret (Statistics and Epidemiology Research Corporation, Seattle) computer programs. The relative risk of H. pylori infection and subsequent lymphoma was determined by the odds ratio with conditional logistic regression²⁵. Statistical tests of the regression coefficients were based on the chi-square approximation for the likelihood-ratio statistic, with confidence intervals estimated by Wald's test. Combined effects of risk factors on the development of gastric lymphoma were explored with statistical tests for interaction. The median values of continuous variables were compared with the Wilcoxon rank-sum test²⁶. Attributable risk was estimated as previously described²⁷.

Results

There were a total of 33 patients with gastric non-Hodgkin's lymphoma (20 from the Kaiser-Orentreich cohort and 13 from the Janus cohort) with 134 matched controls and a total of 31 patients with nongastric non-Hodgkin's lymphoma with 61 matched controls (Table 1). Patients with gastric lymphoma from the Kaiser-Orentreich cohort were significantly older at the time of diagnosis than those from the Janus cohort and were somewhat more likely to be female. These patients were also older at diagnosis than the patients with nongastric lymphoma from the Kaiser-Orentreich cohort. The median interval from serum donation to the diagnosis of cancer was similar in the two groups of patients with gastric lymphoma but was significantly shorter in the group with nongastric lymphoma.

View this table: [in this window] [in a new window]   Table 1. Characteristics of the Patients with Gastric or Nongastric Non-Hodgkin's Lymphoma.

 
Patients with gastric non-Hodgkin's lymphoma were substantially more likely to have had immunologic evidence of prior H. pylori infection than were matched controls (odds ratio, 6.3; 95 percent confidence interval, 2.0 to 19.9) (Table 2). Sixty-six percent of gastric lymphomas could be attributed to H. pylori infection in this population. No association was found between nongastric non-Hodgkin's lymphoma and prior H. pylori infection (odds ratio, 1.2; 95 percent confidence interval, 0.5 to 3.0) (Table 2).

View this table: [in this window] [in a new window]   Table 2. Odds Ratios and 95 Percent Confidence Intervals for the Association of H. pylori Infection with Gastric Non-Hodgkin's Lymphoma and Nongastric Non-Hodgkin's Lymphoma.

 
There was one mismatch between patients and controls with respect to racial or ethnic classification; one Hispanic patient was matched to four Asian controls. This case-control group was completely discordant: the patient had evidence of H. pylori antibodies, but all four controls did not. When this group was excluded from the analysis, evidence of prior H. pylori infection remained linked to gastric non-Hodgkin's lymphoma (odds ratio, 5.5; 95 percent confidence interval, 1.8 to 17.4).

The analysis of the group of patients with gastric lymphoma was also stratified according to cohort, sex, age at diagnosis, and the interval between serum collection and diagnosis. The odds ratio for prior H. pylori infection was elevated in all subgroups (Table 3). There were no statistically significant differences among these subgroups.

View this table: [in this window] [in a new window]   Table 3. Adjusted Odds Ratio and 95 Percent Confidence Intervals for the Association of Gastric Non-Hodgkin's Lymphoma with H. pylori Infection.

 
Three patients with gastric non-Hodgkin's lymphoma were identified as having low-grade MALT lymphoma. This number was too small to assess reliably; 2 of the 3 patients were infected with H. pylori, as compared with 5 of 12 controls (odds ratio, 2.8; 95 percent confidence interval, 0.2 to 28.5). Another patient had a small lymphocytic lymphoma with plasmacytoid features that had no other features indicative of a MALT lymphoma; this patient did not have H. pylori antibodies. The tumors in the remaining 29 patients were classified as diffuse large-cell lymphomas according to the criteria of the working formulation⁴. In this subgroup, the odds ratio for prior H. pylori infection was 7.4 (95 percent confidence interval, 2.1 to 27.0).

Discussion

In this study, patients with gastric non-Hodgkin's lymphoma were substantially more likely than matched controls to have immunologic evidence of prior infection with H. pylori. This association between cancer and infection was found in two large cohorts from different continents. The observed odds ratio probably underestimated the true risk, since a misclassification bias attributable to an imperfect serologic assay would tend to minimize true associations²⁸. Had the ELISA for H. pylori been 100 percent sensitive and 100 percent specific, the odds ratio of lymphoma would have been approximately 25 percent higher.

Studies of Epstein-Barr virus suggest that an aberrant antibody response to infection may occur years before a tumor appears. Such a response is unlikely to explain our findings²⁰. There was no link between nongastric lymphoma and previous infection. Therefore, the finding of an increased risk is not due solely to an abnormal immune response in patients with lymphoma before the disease is diagnosed. Infection with H. pylori was specifically linked to lymphomas of gastric tissue, suggesting that any deleterious effect of this infection is exerted locally.

H. pylori infects approximately half the world's population. Although this infection has been linked to the development of duodenal ulcer, gastric ulcer, hypertrophic gastropathy, and gastric adenocarcinoma, the majority of infected persons remain asymptomatic throughout their lives. Gastric and duodenal ulcers are thought to be caused, at least in part, by H. pylori infection, since the eradication of this microorganism prevents recurrences of these diseases^29,30. It remains possible that H. pylori does not cause cancer but merely signals exposure to other risk factors. Since H. pylori infection is associated with lower socioeconomic status, household crowding, and diminished hygiene,³¹ a different causative factor could be involved rather than the infection itself.

Despite this possibility, we believe that H. pylori is a highly plausible initiator or promoter of gastric lymphoma. Small intestinal lymphomas that develop from immunoproliferative small intestinal disease have previously been linked to bacterial infection³². Other extranodal lymphomas (i.e., thyroid and salivary gland) have been linked to chronic inflammatory processes¹⁷. Furthermore, the stomach, unlike the intestine, is not functionally a lymphoid organ³³. In infancy and early childhood, the stomach is devoid of lymphocytes and plasma cells. With age, however, chronic inflammation can develop, leading lymphocytes to accumulate in the submucosa and gradually increase their depth of penetration. H. pylori infection causes the vast majority of cases of chronic gastritis³⁴. With the eradication of this microorganism, chronic inflammation decreases and the density of submucosal lymphocytes dramatically declines²⁴. Since most gastric non-Hodgkin's lymphomas arise in areas of chronic inflammation,⁸ it seems likely that prior H. pylori infection and this lymphoma are linked.

A recent European study provides evidence that H. pylori has a role in causing a subgroup of gastric lymphomas, low-grade MALT lymphomas³⁵. MALT lymphomas are B-cell lymphomas that arise from lymphoid aggregates in the lamina propria. In that study, MALT lymphomas regressed in response to the treatment of H. pylori infection; in five of six patients, the tumors completely disappeared with the eradication of infection. In a separate investigation, B cells from MALT tumors proliferated in response to H. pylori antigens when incubated in the presence of H. pylori-specific T cells³⁶. Although only 20 to 30 percent of gastric lymphomas appear to arise from clinically evident MALT lymphomas, these few cases may represent a model for H. pylori-related antigenic stimulation, lymphoproliferation, and lymphomagenesis³⁷.

In disrupting the normal physiologic and immunologic processes within the stomach, H. pylori establishes an environment in which proliferation of cells and oxidative damage of DNA may occur in both epithelial and hematopoietic cells. This disruption may manifest itself differently in different persons, perhaps accounting for the variation in risk for H. pylori-related diseases. Differences in response may relate to host factors (age at infection or genetic or immunologic factors), variations between strains (cytotoxin production), or dietary or environmental cofactors (nutritional intake or viral exposure). Therefore, attention should be focused on individual differences in the inflammatory response to H. pylori infection and on factors that influence this response.

The incidence of non-Hodgkin's lymphoma is rising in industrialized countries³⁸. The tumor, however, is not a uniform disease with uniform initiating events. This is particularly true of extranodal non-Hodgkin's lymphoma, of which many cases have been linked to localized inflammatory processes. Studies of the epidemiology and risk factors for non-Hodgkin's lymphoma might best address specific types of tumor and disease locations rather than view these lymphomas as a single entity.

Supported in part by an Ortho Pharmaceutical Corporation Young Investigator Award in Infectious Diseases (to Dr. Parsonnet) and by grants (R35CA49761, CA33119, and CA34233) from the National Cancer Institute (to Dr. Friedman, Dr. Gelb, and Dr. Warnke).

We are indebted to Dr. Nancy Mueller of the Harvard School of Public Health for providing serum from the patients with non-Hodgkin's lymphoma and the controls in the previously studied Kaiser-Orentreich cohort; to Marilyn Replogle, Shufang Yang, and Sandra Chen for technical support; and to Nancy P. Durr for her review of the manuscript.

Source Information

From the Departments of Medicine and Health Research and Policy (J.P., L.R.) and the Department of Pathology (A.B.G., R.A.W.), Stanford University School of Medicine, Stanford, Calif.; the Cancer Registry of Norway, Oslo (S.H.); the Janus Committee, Norwegian Cancer Society, Oslo (E.J.); the Orentreich Foundation for the Advancement of Science, Cold Spring, N.Y. (N.O., J.H.V.); and the Division of Research, Kaiser Permanente Medical Care Program, Oakland, Calif. (G.D.F.).

Address reprint requests to Dr. Parsonnet at HRP Bldg., Rm. 225, Stanford University, Stanford, CA 94305.

References

1. Spiro HM. Clinical gastroenterology. 3rd ed. New York: Macmillan, 1983:292-7. 
2. Severson RK, Davis S. Increasing incidence of primary gastric lymphoma. Cancer 1990;66:1283-1287. [CrossRef][Medline]
3. Rubin E, Farber JL. The gastrointestinal tract. In: Rubin E, Farber JL, eds. Essential pathology. Philadelphia: J.B. Lippincott, 1990:352-92.
4. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982;49:2112-2135. [CrossRef][Medline]
5. Ishido T, Mori N, Kikuchi M, Nakamura K. Primary gastric malignant lymphoma: a morphological and immunohistochemical study of 38 cases. Acta Pathol Jpn 1989;39:229-234. [Medline]
6. Villar HV, Wong R, Paz B, et al. Immunophenotyping in the management of gastric lymphoma. Am J Surg 1991;161:171-175. [Medline]
7. Lee JD, Ko YH, Park JH, Min KR, Park KN. Histological and immunohistochemical studies on primary gastrointestinal lymphomas. J Korean Med Sci 1993;8:17-23. [Medline]
8. Brooks JJ, Enterline HT. Primary gastric lymphomas: a clinicopathologic study of 58 cases with long-term follow-up and literature review. Cancer 1983;51:701-711. [CrossRef][Medline]
9. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-1131. [Abstract]
10. Doglioni C, Wotherspoon AC, Moschini A, de Boni M, Isaacson PG. High incidence of primary gastric lymphoma in northeastern Italy. Lancet 1992;339:834-835. [CrossRef][Medline]
11. Forman D, Sitas F, Newell DG, et al. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer 1990;46:608-611. [Medline]
12. Talley NJ, Zinsmeister AR, Weaver A, et al. Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991;83:1734-1739. [Free Full Text]
13. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-1176. [CrossRef][Medline]
14. Friedman GD, Blaner WS, Goodman DS, et al. Serum retinol and retinol-binding protein levels do not predict subsequent lung cancer. Am J Epidemiol 1986;123:781-789. [Free Full Text]
15. Jellum E, Andersen A, Lund-Larsen P, Theodorsen L, Orjasaeter H. Experiences of the JANUS serum bank in Norway. Environ Health Perspect (in press).
16. Jellum E, Andersen AA, Orjasaeter H, Foss OP, Theodorsen L, Lund-Larsen P. The JANUS serum bank and early detection of cancer. Biochem Clin 1987;11:191-5.
17. Isaacson PG. B cell lymphomas of mucosa associated lymphoid tissue (MALT). Bull Cancer (Paris) 1991;78:203-205.
18. Bindl JM, Warnke RA. Advantages of detecting monoclonal antibody binding to tissue sections with biotin and avidin reagents in Coplin jars. Am J Clin Pathol 1986;85:490-493. [Medline]
19. Ben Rejeb A, Khediri F, Ebdelli N, et al. Apport de l'immunohistochimie en parrafine dans les lymphomes malins du tissu lymphoide associe aux muqueuses (MALT) de l'appareil digestif: a propos de huit observations avec revue complete de la litterature. Arch Anat Cytol Pathol 1992;40:12-22. [Medline]
20. Mueller N, Mohar A, Evans A, et al. Epstein-Barr virus antibody patterns preceding the diagnosis of non-Hodgkin's lymphoma. Int J Cancer 1991;49:387-393. [Medline]
21. Dunn BE. Proteins, antigens and typing methods for Helicobacter pylori. In: Goodwin CS, Worsley BW, eds. Helicobacter pylori: biology and clinical practice. Boca Raton, Fla.: CRC Press, 1993:191-208.
22. Strauss RM, Wang TC, Kelsey PB, et al. Association of Helicobacter pylori infection with dyspeptic symptoms in patients undergoing gastroduodenoscopy. Am J Med 1990;89:464-469. [CrossRef][Medline]
23. Newell DG, Rathbone BJ. The serodiagnosis of Campylobacter pylori infection. Serodiagn Immunother Infect Dis 1989;3:1-6.
24. Kosunen TU, Seppala K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992;339:893-895. [CrossRef][Medline]
25. Conditional logistic regression for matched sets. In: Breslow NE, Day NE. Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. Lyon, France: International Agency for Research on Cancer, 1980:248-79. (IARC scientific publications no. 32).
26. Pagano M, Gauvreau K. Principles of biostatistics. Belmont, Calif.: Wadsworth, 1993:279-82.
27. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. Belmont, Calif.: Lifetime Learning, 1982:159-80.
28. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. Belmont, Calif.: Lifetime Learning, 1982:234-5.
29. Hentschel E, Brandstatter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:308-312. [Free Full Text]
30. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomized, controlled study. Ann Intern Med 1992;116:705-708.
31. Taylor DN, Blaser MJ. The epidemiology of Helicobacter pylori infection. Epidemiol Rev 1991;13:42-59. [Free Full Text]
32. Khojasteh A, Haghshenass M, Haghighi P. Immunoproliferative small intestinal disease: a "third-world lesion." N Engl J Med 1983;308:1401-1405. [Medline]
33. Ming S. Adenocarcinoma and other malignant epithelial tumors of the stomach. In: Ming S-C, Goldman H, eds. Pathology of the gastrointestinal tract. Philadelphia: W.B. Saunders, 1992:584-618.
34. Robert ME, Weinstein WM. Helicobacter pylori-associated gastric pathology. Gastroenterol Clin North Am 1993;22:59-72. [Medline]
35. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-577. [CrossRef][Medline]
36. Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 1993;342:571-574. [CrossRef][Medline]
37. Brooks JJ, Enterline HT. Primary gastric lymphomas: a clinicopathologic study of 58 cases with long-term follow-up and literature review. Cancer 1983;51:701-711.
38. Holford TR, Zheng T, Mayne ST, McKay LA. Time trends of non-Hodgkin's lymphoma: are they real? What do they mean? Cancer Res 1992;52:Suppl:5443s-5446s. [Free Full Text]

Abstract Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Related Letters:

Induction of Fetal Hemoglobin in the Presence of Increased 3-Hydroxybutyric Acid Associated with ß-Ketothiolase Deficiency
Galanello R., Cao A., Olivieri N.
Extract | Full Text  
N Engl J Med 1994; 331:746-747, Sep 15, 1994. Correspondence

This article has been cited by other articles:

• Makobongo, M. O., Kovachi, T., Gancz, H., Mor, A., Merrell, D. S. (2009). In Vitro Antibacterial Activity of Acyl-Lysyl Oligomers against Helicobacter pylori. Antimicrob. Agents Chemother. 53: 4231-4239 [Abstract] [Full Text]  
• Douillard, F. P., Ryan, K. A., Hinds, J., O'Toole, P. W. (2009). Effect of FliK mutation on the transcriptional activity of the {sigma}54 sigma factor RpoN in Helicobacter pylori. Microbiology 155: 1901-1911 [Abstract] [Full Text]  
• Sayi, A., Kohler, E., Hitzler, I., Arnold, I., Schwendener, R., Rehrauer, H., Muller, A. (2009). The CD4+ T Cell-Mediated IFN-{gamma} Response to Helicobacter Infection Is Essential for Clearance and Determines Gastric Cancer Risk. J. Immunol. 182: 7085-7101 [Abstract] [Full Text]  
• Hung, I. F.N., Wong, B. C.Y. (2009). Assessing the risks and benefits of treating Helicobacter pylori infection. Therapeutic Advances in Gastroenterology 2: 141-147  
• Jones, K. R., Joo, Y. M., Jang, S., Yoo, Y.-J., Lee, H. S., Chung, I.-S., Olsen, C. H., Whitmire, J. M., Merrell, D. S., Cha, J.-H. (2009). Polymorphism in the CagA EPIYA Motif Impacts Development of Gastric Cancer. J. Clin. Microbiol. 47: 959-968 [Abstract] [Full Text]  
• Bergsagel, P. L. (2009). Syk to death. Blood 113: 2371-2371 [Full Text]  
• Gupta, S. S., Borin, B. N., Cover, T. L., Krezel, A. M. (2009). Structural Analysis of the DNA-binding Domain of the Helicobacter pylori Response Regulator ArsR. J. Biol. Chem. 284: 6536-6545 [Abstract] [Full Text]  
• Psyrri, A., Papageorgiou, S., Economopoulos, T. (2008). Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management. Ann Oncol 19: 1992-1999 [Abstract] [Full Text]  
• Lee, Y.-C., Liou, J.-M., Wu, C.-Y., Lin, J.-T. (2008). Review: Eradication of Helicobacter pylori to prevent gastroduodenal diseases: Hitting more than one bird with the same stone. Therapeutic Advances in Gastroenterology 1: 111-120 [Abstract]  
• Sjo, L. D., Ralfkiaer, E., Prause, J. U., Petersen, J. H., Madsen, J., Pedersen, N. T., Heegaard, S. (2008). Increasing Incidence of Ophthalmic Lymphoma in Denmark from 1980 to 2005. IOVS 49: 3283-3288 [Abstract] [Full Text]  
• Shibata, W., Maeda, S., Hikiba, Y., Yanai, A., Sakamoto, K., Nakagawa, H., Ogura, K., Karin, M., Omata, M. (2008). c-Jun NH2-Terminal Kinase 1 Is a Critical Regulator for the Development of Gastric Cancer in Mice. Cancer Res. 68: 5031-5039 [Abstract] [Full Text]  
• Corley, D A, Kubo, A, Levin, T R, Block, G, Habel, L, Zhao, W, Leighton, P, Rumore, G, Quesenberry, C, Buffler, P, Parsonnet, J (2008). Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut 57: 727-733 [Abstract] [Full Text]  
• Blaser, M. J. (2008). Understanding Microbe-Induced Cancers. Cancer Prevention Research 1: 15-20 [Abstract] [Full Text]  
• de Martel, C., Llosa, A. E., Friedmana, G. D., Vogelman, J. H., Orentreich, N., Stolzenberg-Solomon, R. Z., Parsonnet, J. (2008). Helicobacter pylori Infection and Development of Pancreatic Cancer. Cancer Epidemiol. Biomarkers Prev. 17: 1188-1194 [Abstract] [Full Text]  
• Blaser, M. J, Chen, Y., Reibman, J. (2008). Does Helicobacter pylori protect against asthma and allergy?. Gut 57: 561-567 [Full Text]  
• Lee, S.-B., Yang, J.-W., Kim, C.-S. (2008). The association between conjunctival MALT lymphoma and Helicobacter pylori. Br J Ophthalmol 92: 534-536 [Abstract] [Full Text]  
• Ohnishi, N., Yuasa, H., Tanaka, S., Sawa, H., Miura, M., Matsui, A., Higashi, H., Musashi, M., Iwabuchi, K., Suzuki, M., Yamada, G., Azuma, T., Hatakeyama, M. (2008). Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc. Natl. Acad. Sci. USA 105: 1003-1008 [Abstract] [Full Text]  
• Rubesin, S. E., Levine, M. S., Laufer, I. (2008). Double-Contrast Upper Gastrointestinal Radiography: A Pattern Approach for Diseases of the Stomach. Radiology 246: 33-48 [Abstract] [Full Text]  
• Ryan, E. T., Aquino, S. L., Kradin, R. L. (2007). Case 29-2007 -- A 51-Year-Old Man with Gastric Cancer and Lung Nodules. NEJM 357: 1239-1246 [Full Text]  
• Tsukamoto, T., Mizoshita, T., Tatematsu, M. (2007). Animal Models of Stomach Carcinogenesis. Toxicol Pathol 35: 636-648 [Abstract] [Full Text]  
• Pillinger, M. H., Marjanovic, N., Kim, S.-Y., Lee, Y.-C., Scher, J. U., Roper, J., Abeles, A. M., Izmirly, P. I., Axelrod, M., Pillinger, M. Y., Tolani, S., Dinsell, V., Abramson, S. B., Blaser, M. J. (2007). Helicobacter pylori Stimulates Gastric Epithelial Cell MMP-1 Secretion via CagA-dependent and -independent ERK Activation. J. Biol. Chem. 282: 18722-18731 [Abstract] [Full Text]  
• Lottspeich, C., Schwarzer, A., Panthel, K., Koletzko, S., Russmann, H. (2007). Evaluation of the Novel Helicobacter pylori ClariRes Real-Time PCR Assay for Detection and Clarithromycin Susceptibility Testing of H. pylori in Stool Specimens from Symptomatic Children. J. Clin. Microbiol. 45: 1718-1722 [Abstract] [Full Text]  
• Seshadri, S., Benoit, S. L., Maier, R. J. (2007). Roles of His-Rich Hpn and Hpn-Like Proteins in Helicobacter pylori Nickel Physiology. J. Bacteriol. 189: 4120-4126 [Abstract] [Full Text]  
• Corley, D. A, Kubo, A., Zhao, W. (2007). Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut 56: 756-762 [Abstract] [Full Text]  
• Gribben, J. G. (2007). How I treat indolent lymphoma. Blood 109: 4617-4626 [Abstract] [Full Text]  
• Bacon, C. M, Du, M.-Q., Dogan, A. (2007). Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists. J. Clin. Pathol. 60: 361-372 [Abstract] [Full Text]  
• Polenghi, A., Bossi, F., Fischetti, F., Durigutto, P., Cabrelle, A., Tamassia, N., Cassatella, M. A., Montecucco, C., Tedesco, F., de Bernard, M. (2007). The Neutrophil-Activating Protein of Helicobacter pylori Crosses Endothelia to Promote Neutrophil Adhesion In Vivo. J. Immunol. 178: 1312-1320 [Abstract] [Full Text]  
• Narimatsu, H, Ota, Y, Kami, M, Takeuchi, K, Suzuki, R, Matsuo, K, Matsumura, T, Yuji, K, Kishi, Y, Hamaki, T, Sawada, U, Miyata, S, Sasaki, T, Tobinai, K, Kawabata, M, Atsuta, Y, Tanaka, Y, Ueda, R, Nakamura, S (2007). Clinicopathological features of pyothorax-associated lymphoma; a retrospective survey involving 98 patients. Ann Oncol 18: 122-128 [Abstract] [Full Text]  
• Arcaini, L., Burcheri, S., Rossi, A., Pascutto, C., Passamonti, F., Brusamolino, E., Paulli, M., Orlandi, E., Buelli, M., Viero, P., Lucioni, M., Montanari, F., Merli, M., Cortelazzo, S., Lazzarino, M. (2007). Risk of Second Cancer in Nongastric Marginal Zone B-Cell Lymphomas of Mucosa-Associated Lymphoid Tissue: A Population-Based Study from Northern Italy. Clin. Cancer Res. 13: 182-186 [Abstract] [Full Text]  
• Cohen, S. M., Petryk, M., Varma, M., Kozuch, P. S., Ames, E. D., Grossbard, M. L. (2006). Non-Hodgkin's Lymphoma of Mucosa-Associated Lymphoid Tissue. The Oncologist 11: 1100-1117 [Abstract] [Full Text]  
• Kusters, J. G., van Vliet, A. H. M., Kuipers, E. J. (2006). Pathogenesis of Helicobacter pylori Infection. Clin. Microbiol. Rev. 19: 449-490 [Abstract] [Full Text]  
• Bussiere, F. I., Chaturvedi, R., Asim, M., Hoek, K. L., Cheng, Y., Gainor, J., Scholz, A., Khan, W. N., Wilson, K. T. (2006). Low Multiplicity of Infection of Helicobacter pylori Suppresses Apoptosis of B Lymphocytes.. Cancer Res. 66: 6834-6842 [Abstract] [Full Text]  
• Suzuki, T., Matsuo, K., Ito, H., Hirose, K., Wakai, K., Saito, T., Sato, S., Morishima, Y., Nakamura, S., Ueda, R., Tajima, K. (2006). A past history of gastric ulcers and Helicobacter pylori infection increase the risk of gastric malignant lymphoma. Carcinogenesis 27: 1391-1397 [Abstract] [Full Text]  
• Tran, A. X., Whittimore, J. D., Wyrick, P. B., McGrath, S. C., Cotter, R. J., Trent, M. S. (2006). The Lipid A 1-Phosphatase of Helicobacter pylori Is Required for Resistance to the Antimicrobial Peptide Polymyxin.. J. Bacteriol. 188: 4531-4541 [Abstract] [Full Text]  
• Nossa, C. W., Blanke, S. R. (2006). Modification of a Mammalian Cell Protein in the Presence of [32P-Adenylate]NAD: Evidence for ADP Ribosylation Activity Associated with Helicobacter pylori.. Infect. Immun. 74: 3071-3076 [Abstract] [Full Text]  
• Letley, D. P., Rhead, J. L., Bishop, K., Atherton, J. C. (2006). Paired cysteine residues are required for high levels of the Helicobacter pylori autotransporter VacA.. Microbiology 152: 1319-1325 [Abstract] [Full Text]  
• Suarez, F., Lortholary, O., Hermine, O., Lecuit, M. (2006). Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood 107: 3034-3044 [Abstract] [Full Text]  
• Grunberger, B., Wohrer, S., Streubel, B., Formanek, M., Petkov, V., Puespoek, A., Haefner, M., Hejna, M., Jaeger, U., Chott, A., Raderer, M. (2006). Antibiotic Treatment Is Not Effective in Patients Infected With Helicobacter pylori Suffering From Extragastric MALT Lymphoma. JCO 24: 1370-1375 [Abstract] [Full Text]  
• Genisset, C., Galeotti, C. L., Lupetti, P., Mercati, D., Skibinski, D. A. G., Barone, S., Battistutta, R., de Bernard, M., Telford, J. L. (2006). A Helicobacter pylori Vacuolating Toxin Mutant That Fails To Oligomerize Has a Dominant Negative Phenotype. Infect. Immun. 74: 1786-1794 [Abstract] [Full Text]  
• Wen, Y., Feng, J., Scott, D. R., Marcus, E. A., Sachs, G. (2006). Involvement of the HP0165-HP0166 Two-Component System in Expression of Some Acidic-pH-Upregulated Genes of Helicobacter pylori.. J. Bacteriol. 188: 1750-1761 [Abstract] [Full Text]  
• Francois, F., Blaser, M. J. (2006). Improving Helicobacter pylori Eradication Regimens. ANN INTERN MED 144: 140-141 [Full Text]  
• Lane, M. C., O'Toole, P. W., Moore, S. A. (2006). Molecular Basis of the Interaction between the Flagellar Export Proteins FliI and FliH from Helicobacter pylori. J. Biol. Chem. 281: 508-517 [Abstract] [Full Text]  
• Ohmae, T., Hirata, Y., Maeda, S., Shibata, W., Yanai, A., Ogura, K., Yoshida, H., Kawabe, T., Omata, M. (2005). Helicobacter pylori Activates NF-{kappa}B via the Alternative Pathway in B Lymphocytes. J. Immunol. 175: 7162-7169 [Abstract] [Full Text]  
• Bertoni, F., Zucca, E. (2005). State-of-the-Art Therapeutics: Marginal-Zone Lymphoma. JCO 23: 6415-6420 [Abstract] [Full Text]  
• Mueller, A., O'Rourke, J., Chu, P., Chu, A., Dixon, M. F., Bouley, D. M., Lee, A., Falkow, S. (2005). The Role of Antigenic Drive and Tumor-Infiltrating Accessory Cells in the Pathogenesis of Helicobacter-Induced Mucosa-Associated Lymphoid Tissue Lymphoma. Am. J. Pathol. 167: 797-812 [Abstract] [Full Text]  
• Ryan, K. A., Karim, N., Worku, M., Penn, C. W., O'Toole, P. W. (2005). Helicobacter pylori Flagellar Hook-Filament Transition Is Controlled by a FliK Functional Homolog Encoded by the Gene HP0906. J. Bacteriol. 187: 5742-5750 [Abstract] [Full Text]  
• Deml, L., Aigner, M., Decker, J., Eckhardt, A., Schutz, C., Mittl, P. R. E., Barabas, S., Denk, S., Knoll, G., Lehn, N., Schneider-Brachert, W. (2005). Characterization of the Helicobacter pylori Cysteine-Rich Protein A as a T-Helper Cell Type 1 Polarizing Agent. Infect. Immun. 73: 4732-4742 [Abstract] [Full Text]  
• Levy, M., Copie-Bergman, C., Gameiro, C., Chaumette, M.-T., Delfau-Larue, M.-H., Haioun, C., Charachon, A., Hemery, F., Gaulard, P., Leroy, K., Delchier, J.-C. (2005). Prognostic Value of Translocation t(11;18) in Tumoral Response of Low-Grade Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue Type to Oral Chemotherapy. JCO 23: 5061-5066 [Abstract] [Full Text]  
• Zucca, E., Bertoni, F. (2005). Another Piece of the MALT Lymphomas Jigsaw. JCO 23: 4832-4834 [Full Text]  
• Yeh, K.-H., Kuo, S.-H., Chen, L.-T., Mao, T.-L., Doong, S.-L., Wu, M.-S., Hsu, H.-C., Tzeng, Y.-S., Chen, C.-L., Lin, J.-T., Cheng, A.-L. (2005). Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21). Blood 106: 1037-1041 [Abstract] [Full Text]  
• Kranzer, K., Sollner, L., Aigner, M., Lehn, N., Deml, L., Rehli, M., Schneider-Brachert, W. (2005). Impact of Helicobacter pylori Virulence Factors and Compounds on Activation and Maturation of Human Dendritic Cells. Infect. Immun. 73: 4180-4189 [Abstract] [Full Text]  
• Schar, J., Sickmann, A., Beier, D. (2005). Phosphorylation-Independent Activity of Atypical Response Regulators of Helicobacter pylori. J. Bacteriol. 187: 3100-3109 [Abstract] [Full Text]  
• Lin, S.-N., Ayada, K., Zhao, Y., Yokota, K., Takenaka, R., Okada, H., Kan, R., Hayashi, S., Mizuno, M., Hirai, Y., Fujinami, Y., Oguma, K. (2005). Helicobacter pylori heat-shock protein 60 induces production of the pro-inflammatory cytokine IL8 in monocytic cells. J Med Microbiol 54: 225-233 [Abstract] [Full Text]  
• Terio, K. A., Munson, L., Marker, L., Aldridge, B. M., Solnick, J. V. (2005). Comparison of Helicobacter spp. in Cheetahs (Acinonyx jubatus) with and without Gastritis. J. Clin. Microbiol. 43: 229-234 [Abstract] [Full Text]  
• Matsumoto, M., Hara, K., Kimata, H., Benno, Y., Shimamoto, C. (2005). Exfoliation of Helicobacter pylori from Gastric Mucin by Glycopolypeptides from Buttermilk. J DAIRY SCI 88: 49-54 [Abstract] [Full Text]  
• Zhang, S., Tsai, S., Wu, T. T., Li, B., Shih, J. W.-K., Lo, S.-C. (2004). Mycoplasma fermentans infection promotes immortalization of human peripheral blood mononuclear cells in culture. Blood 104: 4252-4259 [Abstract] [Full Text]  
• Takenaka, R., Yokota, K., Ayada, K., Mizuno, M., Zhao, Y., Fujinami, Y., Lin, S.-N., Toyokawa, T., Okada, H., Shiratori, Y., Oguma, K. (2004). Helicobacter pylori heat-shock protein 60 induces inflammatory responses through the Toll-like receptor-triggered pathway in cultured human gastric epithelial cells. Microbiology 150: 3913-3922 [Abstract] [Full Text]  
• Horie, K., Horie, N., Abdou, A. M., Yang, J.-O., Yun, S.-S., Chun, H.-N., Park, C.-K., Kim, M., Hatta, H. (2004). Suppressive Effect of Functional Drinking Yogurt Containing Specific Egg Yolk Immunoglobulin on Helicobacter pylori in Humans. J DAIRY SCI 87: 4073-4079 [Abstract] [Full Text]  
• Wang, K.-Y., Li, S.-N., Liu, C.-S., Perng, D.-S., Su, Y.-C., Wu, D.-C., Jan, C.-M., Lai, C.-H., Wang, T.-N., Wang, W.-M. (2004). Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am. J. Clin. Nutr. 80: 737-741 [Abstract] [Full Text]  
• Kuo, S.-H., Chen, L.-T., Yeh, K.-H., Wu, M.-S., Hsu, H.-C., Yeh, P.-Y., Mao, T.-L., Chen, C.-L., Doong, S.-L., Lin, J.-T., Cheng, A.-L. (2004). Nuclear Expression of BCL10 or Nuclear Factor Kappa B Predicts Helicobacter pylori-Independent Status of Early-Stage, High-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphomas. JCO 22: 3491-3497 [Abstract] [Full Text]  
• Akhiani, A. A., Schon, K., Lycke, N. (2004). Vaccine-Induced Immunity against Helicobacter pylori Infection Is Impaired in IL-18-Deficient Mice. J. Immunol. 173: 3348-3356 [Abstract] [Full Text]  
• Kranzer, K., Eckhardt, A., Aigner, M., Knoll, G., Deml, L., Speth, C., Lehn, N., Rehli, M., Schneider-Brachert, W. (2004). Induction of Maturation and Cytokine Release of Human Dendritic Cells by Helicobacter pylori. Infect. Immun. 72: 4416-4423 [Abstract] [Full Text]  
• Lehours, P, Dupouy, S, Bergey, B, Ruskone-Foumestraux, A, Delchier, J C, Rad, R, Richy, F, Tankovic, J, Zerbib, F, Megraud, F, Menard, A (2004). Identification of a genetic marker of Helicobacter pylori strains involved in gastric extranodal marginal zone B cell lymphoma of the MALT-type. Gut 53: 931-937 [Abstract] [Full Text]  
• de Paulis, A., Prevete, N., Fiorentino, I., Walls, A. F., Curto, M., Petraroli, A., Castaldo, V., Ceppa, P., Fiocca, R., Marone, G. (2004). Basophils Infiltrate Human Gastric Mucosa at Sites of Helicobacter pylori Infection, and Exhibit Chemotaxis in Response to H. pylori-derived Peptide Hp(2-20). J. Immunol. 172: 7734-7743 [Abstract] [Full Text]  
• de Sanjose, S., Dickie, A., Alvaro, T., Romagosa, V., Garcia Villanueva, M., Domingo-Domenech, E., Fernandez de Sevilla, A., El-Omar, E. (2004). Helicobacter pylori and Malignant Lymphoma in Spain. Cancer Epidemiol. Biomarkers Prev. 13: 944-948 [Abstract] [Full Text]  
• Kim, S., Chamberlain, A. K., Bowie, J. U. (2004). Membrane channel structure of Helicobacter pylori vacuolating toxin: Role of multiple GXXXG motifs in cylindrical channels. Proc. Natl. Acad. Sci. USA 101: 5988-5991 [Abstract] [Full Text]  
• Peterson, M. C., Lecuit, M., Suarez, F., Lortholary, O. (2004). Immunoproliferative Small Intestinal Disease Associated with Campylobacter jejuni. NEJM 350: 1685-1686 [Full Text]  
• Akhiani, A. A., Schon, K., Franzen, L. E., Pappo, J., Lycke, N. (2004). Helicobacter pylori-Specific Antibodies Impair the Development of Gastritis, Facilitate Bacterial Colonization, and Counteract Resistance against Infection. J. Immunol. 172: 5024-5033 [Abstract] [Full Text]  
• Salaun, L., Linz, B., Suerbaum, S., Saunders, N. J. (2004). The diversity within an expanded and redefined repertoire of phase-variable genes in Helicobacter pylori. Microbiology 150: 817-830 [Abstract] [Full Text]  
• Toyokawa, T., Yokota, K., Mizuno, M., Fujinami, Y., Takenaka, R., Okada, H., Hayashi, S., Hirai, Y., Oguma, K., Shiratori, Y. (2004). Characterization of elongated Helicobacter pylori isolated from a patient with gastric-mucosa-associated lymphoid-tissue lymphoma. J Med Microbiol 53: 207-212 [Abstract] [Full Text]  
• Lehours, P., Menard, A., Dupouy, S., Bergey, B., Richy, F., Zerbib, F., Ruskone-Fourmestraux, A., Delchier, J. C., Megraud, F. (2004). Evaluation of the Association of Nine Helicobacter pylori Virulence Factors with Strains Involved in Low-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. Infect. Immun. 72: 880-888 [Abstract] [Full Text]  
• Sgouras, D., Maragkoudakis, P., Petraki, K., Martinez-Gonzalez, B., Eriotou, E., Michopoulos, S., Kalantzopoulos, G., Tsakalidou, E., Mentis, A. (2004). In Vitro and In Vivo Inhibition of Helicobacter pylori by Lactobacillus casei Strain Shirota. Appl. Environ. Microbiol. 70: 518-526 [Abstract] [Full Text]  
• Mitchell, D. J., Huynh, H. Q., Ceponis, P. J. M., Jones, N. L., Sherman, P. M. (2004). Helicobacter pylori Disrupts STAT1-Mediated Gamma Interferon-Induced Signal Transduction in Epithelial Cells. Infect. Immun. 72: 537-545 [Abstract] [Full Text]  
• Fischbach, W, Goebeler-Kolve, M-E, Dragosics, B, Greiner, A, Stolte, M (2004). Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 53: 34-37 [Abstract] [Full Text]  
• Yamasaki, R., Yokota, K., Okada, H., Hayashi, S., Mizuno, M., Yoshino, T., Hirai, Y., Saitou, D., Akagi, T., Oguma, K. (2004). Immune response in Helicobacter pylori-induced low-grade gastric-mucosa-associated lymphoid tissue (MALT) lymphoma. J Med Microbiol 53: 21-29 [Abstract] [Full Text]  
• Willhite, D. C., Cover, T. L., Blanke, S. R. (2003). Cellular Vacuolation and Mitochondrial Cytochrome c Release Are Independent Outcomes of Helicobacter pylori Vacuolating Cytotoxin Activity That Are Each Dependent on Membrane Channel Formation. J. Biol. Chem. 278: 48204-48209 [Abstract] [Full Text]  
• Tsang, R. W., Gospodarowicz, M. K., Pintilie, M., Wells, W., Hodgson, D. C., Sun, A., Crump, M., Patterson, B. J. (2003). Localized Mucosa-Associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy Has Excellent Clinical Outcome. JCO 21: 4157-4164 [Abstract] [Full Text]  
• Gniadecki, R., Lukowsky, A., Rossen, K., Madsen, H. O., Thomsen, K., Wulf, H. C. (2003). Bone marrow precursor of extranodal T-cell lymphoma. Blood 102: 3797-3799 [Abstract] [Full Text]  
• Rizos, K., Lattemann, C. T., Bumann, D., Meyer, T. F., Aebischer, T. (2003). Autodisplay: Efficacious Surface Exposure of Antigenic UreA Fragments from Helicobacter pylori in Salmonella Vaccine Strains. Infect. Immun. 71: 6320-6328 [Abstract] [Full Text]  
• Aljurf, M. D., Owaidah, T. W., Ezzat, A., Ibrahim, E., Tbakhi, A. (2003). Antigen- and/or immune-driven lymphoproliferative disorders. Ann Oncol 14: 1595-1606 [Full Text]  
• Bergonzelli, G. E., Donnicola, D., Porta, N., Corthesy-Theulaz, I. E. (2003). Essential Oils as Components of a Diet-Based Approach to Management of Helicobacter Infection. Antimicrob. Agents Chemother. 47: 3240-3246 [Abstract] [Full Text]  
• Panthel, K., Dietz, P., Haas, R., Beier, D. (2003). Two-Component Systems of Helicobacter pylori Contribute to Virulence in a Mouse Infection Model. Infect. Immun. 71: 5381-5385 [Abstract] [Full Text]  
• Nagata, K., Nagata, Y., Sato, T., Fujino, M. A., Nakajima, K., Tamura, T. (2003). L-Serine, D- and L-proline and alanine as respiratory substrates of Helicobacter pylori: correlation between in vitro and in vivo amino acid levels. Microbiology 149: 2023-2030 [Abstract] [Full Text]  
• Letley, D. P., Rhead, J. L., Twells, R. J., Dove, B., Atherton, J. C. (2003). Determinants of Non-toxicity in the Gastric Pathogen Helicobacter pylori. J. Biol. Chem. 278: 26734-26741 [Abstract] [Full Text]  
• Bebb, J. R., Letley, D. P., Rhead, J. L., Atherton, J. C. (2003). Helicobacter pylori Supernatants Cause Epithelial Cytoskeletal Disruption That Is Bacterial Strain and Epithelial Cell Line Dependent but Not Toxin VacA Dependent. Infect. Immun. 71: 3623-3627 [Abstract] [Full Text]  
• Straubinger, R. K., Greiter, A., McDonough, S. P., Gerold, A., Scanziani, E., Soldati, S., Dailidiene, D., Dailide, G., Berg, D. E., Simpson, K. W. (2003). Quantitative Evaluation of Inflammatory and Immune Responses in the Early Stages of Chronic Helicobacter pylori Infection. Infect. Immun. 71: 2693-2703 [Abstract] [Full Text]  
• Ba-Ssalamah, A., Prokop, M., Uffmann, M., Pokieser, P., Teleky, B., Lechner, G. (2003). Dedicated Multidetector CT of the Stomach: Spectrum of Diseases. RadioGraphics 23: 625-644 [Abstract] [Full Text]  
• Loughlin, M. F., Barnard, F. M., Jenkins, D., Sharples, G. J., Jenks, P. J. (2003). Helicobacter pylori Mutants Defective in RuvC Holliday Junction Resolvase Display Reduced Macrophage Survival and Spontaneous Clearance from the Murine Gastric Mucosa. Infect. Immun. 71: 2022-2031 [Abstract] [Full Text]  
• Okabe, M., Inagaki, H., Ohshima, K., Yoshino, T., Li, C., Eimoto, T., Ueda, R., Nakamura, S. (2003). API2-MALT1 Fusion Defines a Distinctive Clinicopathologic Subtype in Pulmonary Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue. Am. J. Pathol. 162: 1113-1122 [Abstract] [Full Text]  
• Berkes, J, Viswanathan, V K, Savkovic, S D, Hecht, G (2003). Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 52: 439-451 [Abstract] [Full Text]  
• Koehler, C I, Mues, M B, Dienes, H P, Kriegsmann, J, Schirmacher, P, Odenthal, M (2003). Helicobacter pylori genotyping in gastric adenocarcinoma and MALT lymphoma by multiplex PCR analyses of paraffin wax embedded tissues. Mol. Pathol. 56: 36-42 [Abstract] [Full Text]  
• Jiang, W., Baker, H. J., Smith, B. F. (2003). Mucosal Immunization with Helicobacter, CpG DNA, and Cholera Toxin Is Protective. Infect. Immun. 71: 40-46 [Abstract] [Full Text]  
• Akhiani, A. A., Pappo, J., Kabok, Z., Schon, K., Gao, W., Franzen, L. E., Lycke, N. (2002). Protection Against Helicobacter pylori Infection Following Immunization Is IL-12-Dependent and Mediated by Th1 Cells. J. Immunol. 169: 6977-6984 [Abstract] [Full Text]  
• Ananieva, O., Nilsson, I., Vorobjova, T., Uibo, R., Wadstrom, T. (2002). Immune Responses to Bile-Tolerant Helicobacter Species in Patients with Chronic Liver Diseases, a Randomized Population Group, and Healthy Blood Donors. CVI 9: 1160-1164 [Abstract] [Full Text]  
• Dye, B. A., Kruszon-Moran, D., McQuillan, G. (2002). The Relationship Between Periodontal Disease Attributes and Helicobacter pylori Infection Among Adults in the United States. AJPH 92: 1809-1815 [Abstract] [Full Text]  
• Suerbaum, S., Michetti, P. (2002). Helicobacter pylori Infection. NEJM 347: 1175-1186 [Full Text]  
• Cottet, S., Corthesy-Theulaz, I., Spertini, F., Corthesy, B. (2002). Microaerophilic Conditions Permit to Mimic in Vitro Events Occurring during in Vivo Helicobacter pylori Infection and to Identify Rho/Ras-associated Proteins in Cellular Signaling. J. Biol. Chem. 277: 33978-33986 [Abstract] [Full Text]  
• Shin, J.-H., Yang, M., Nam, S. W., Kim, J. T., Myung, N. H., Bang, W.-G., Roe, I. H. (2002). Use of Egg Yolk-Derived Immunoglobulin as an Alternative to Antibiotic Treatment for Control of Helicobacter pylori Infection. CVI 9: 1061-1066 [Abstract] [Full Text]  
• Xu, Q., Morgan, R. D., Roberts, R. J., Xu, S. Y., van Doorn, L. J., Donahue, J. P., Miller, G. G., Blaser, M. J. (2002). Functional analysis of iceA1, a CATG-recognizing restriction endonuclease gene in Helicobacter pylori. Nucleic Acids Res 30: 3839-3847 [Abstract] [Full Text]